The hexosamine biosynthesis pathway is a targetable liability in lung cancers with concurrent KRAS and LKB1 mutations
Author: J Kim, F Cai, B Ko, C Yang, HM Lee, N Muhammad, et al.
Year Published: 2020
Media Outlet: Nature
Open Access? Yes
Matrix: Tissue
Biological Themes: Cell proliferation and cell cycle, Lung function
Product(s): Global Discovery Panel
Cited in over 3,000 publications, we help scientists and manufacturers gain greater insight into their studies through metabolomics.
GET STARTED
Talk with an expert
Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.
Find us on:
